Article Text

Download PDFPDF
Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas
  1. J Haapasalo1,
  2. A Mennander2,
  3. P Helen3,
  4. H Haapasalo,
  5. J Isola4
  1. 1University of Turku, Turku, FIN-20520, Finland
  2. 2Heart Centre, Tampere University Hospital, Tampere, Finland
  3. 3Department of Neurosurgery, Tampere University Hospital
  4. 4Institute of Medical Technology, University of Tampere, Tampere, FIN-33014, Finland
  1. Correspondence to:
 Dr H Haapasalo
 Department of Pathology, Tampere University Hospital, PO Box 2000, FIN-33521 Tampere, Finland; hannu.haapasalopshp.fi

Abstract

Background: Astrocytic tumours, the most common gliomas, are often classified intraoperatively using standard morphological staining. The final diagnosis and grading of gliomas on paraffin wax sections is often assisted by Ki-67 immunohistochemistry, but standard immunostaining protocols take too long to be used intraoperatively.

Aims: To investigate a new rapid Ki-67 immunohistochemical test for its use in an intraoperative setting.

Methods: The new Ki-67 immunostaining (Ultrarapid-Ki67®) method on frozen sections can be carried out in 10 minutes. Thirty four pilocytic and diffuse astrocytomas were immunostained by rapid Ki-67 and results were compared with corresponding MIB-1 staining, histological grading, and prognosis.

Results: The staining protocol was practical to perform and the results were morphologically and quantitatively indistinguishable from those after immunostaining with MIB-1, an antibody recognising Ki-67 in paraffin wax embedded tissue. A comparison of Ultrarapid-Ki67 and MIB-1 immunostaining of paraffin wax sections showed almost identical quantitative correlation in astrocytic gliomas (r = 0.916; p<0.001). The Ultrarapid-Ki67 indices (percentage of positive cells) of low grade (I/II) astrocytomas ranged from 0% to 6.1%, whereas those of representative high grade (III/IV) tumours were significantly higher (range, 5.6–45%; p<0.001). The best prognostic cutoff point for Ultrarapid-Ki67 was 7.5%, which divided diffuse grade II–IV astrocytomas into significantly differing subsets (p = 0.0008).

Conclusion: Ultrarapid-Ki67 immunostaining is a useful adjunct to morphological diagnosis and grading of astrocytic tumours, and as a fast test (∼10 minutes for staining plus three to four minutes for scoring), it could be used in routine intraoperative diagnosis of gliomas and other neoplastic diseases.

  • DAB, diaminobenzidine
  • HE, haematoxylin and eosin
  • IHC, immunohistochemistry
  • ROC, receiver operating characteristics
  • WHO, World Health Organisation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes